About The Study: In this cross-sectional study, early age–onset colorectal cancer (EOCRC) was associated with improved overall survival compared with average age–onset colorectal cancer; however, treatment delays were independently associated with worse survival among patients with EOCRC. Language barriers could be a potentially modifiable risk factor associated with delayed treatment and may provide an opportunity to improve timely care and outcomes in EOCRC. 

More people are surviving the wait for an organ and organ transplantation surgery, but the gap between the number of patients who need transplants and those who receive them remains large.

To Joseph Sugerman, MD, a leading ear, nose and throat (ENT) specialist in Beverly Hills, human vocal cords are like finely tuned guitar strings or violins. They can be easily damaged by wear and tear and require the best of care to last a lifetime. For nearly 50 years, Dr. Sugerman has been providing patient-centered, personalized care to performers and non-performers alike, helping them preserve and restore their voices and prevent and treat hearing loss, as well as other conditions of the ear, nose and throat. Now, singer/songwriter Stevie Nicks—the first woman inducted twice into the Rock and Roll Hall of Fame—has made a major gift to establish the Stevie Nicks and Joseph Sugerman, MD, Endowed Chair in Otolaryngology at Keck School of Medicine of USC. Her contribution completed the $3 million goal for the endowed chair, which was also supported by generous gifts from other donors, all seeking to honor their longtime friend and caregiver. The inaugural holder of the Stevie Nicks and Joseph Sugerman, MD, Endowed Chair in Otolaryngology is Michael M. Johns, MD, director of the USC Voice Center, and a world-class expert in professional voice care. The idea to recognize Dr. Sugerman’s accomplishments by raising $3 million to establish an endowed chair came from Anita May Rosenstein and her husband, Arnold. Other patients quickly stepped forward to express their gratitude to their one-of-a-kind ENT physician. The giving cohort includes the Bloomfield Family Foundation, Barbara and Gary Brandt Family Foundation, James & Deborah Burrows Foundation, Crawford Family Foundation, Anne and Kirk Douglas Foundation, Lowell Milken Family Foundation, Arnold & Anita Rosenstein Family Foundation, The Fran and Ray Stark Foundation, and Howard Ruby. 

A trial co-led by Stanford Medicine researchers found that a new drug, obexelimab, can be used to effectively treat patients with the rare immune condition known as IgG4-related disease.